| ￥6600 | |
| Z04518-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Conjugate | Biotin | ||||||
| Purity | > 95% as determined by BisTris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 111.8 kDa (ITGA5) & 83.2 kDa (ITGB1) | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 110-140 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized Integrin alpha 5 beta 1 (ITGA5&ITGB1) Heterodimer[Biotin], His & Avi, Human, His-Avi Tag at 0.5 μg/ml (100 μl/Well) on streptavidin(5 μg/ml) precoated plate. Dose response curve for Anti-?? Antibody, hFc Tag with the EC50 of 32.2ng/ml determined by ELISA. »
The purity of Integrin alpha 5 beta 1 (ITGA5&ITGB1) Heterodimer[Biotin], His & Avi, Human is greater than 90% as determined by SEC-HPLC. »
Integrin alpha 5 beta 1 (ITGA5&ITGB1) Heterodimer[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Integrin alpha 5/ beta 1, also known as VLA-5, is a widely expressed non-covalent heterodimer of a 160 kDa alpha 5 and a 130 kDa beta 1 Integrin subunit.Alpha 5/ beta 1 is up‑regulated on tumor vasculature and promotes angiogenesis. |
| Synonyms | Integrin alpha 5 beta 1; VLA-5; ITGA5&ITGB1; Integrin alpha 5 β 1; α5β1 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
